Cargando…

Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway

BACKGROUND: It is well known that methamphetamine (METH) is neurotoxic and recent studies have suggested the involvement of neuroinflammatory processes in brain dysfunction induced by misuse of this drug. Indeed, glial cells seem to be activated in response to METH, but its effects on microglial cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho-Santos, Vanessa, Gonçalves, Joana, Fontes-Ribeiro, Carlos, Silva, Ana Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391183/
https://www.ncbi.nlm.nih.gov/pubmed/22642790
http://dx.doi.org/10.1186/1742-2094-9-103
_version_ 1782237489153441792
author Coelho-Santos, Vanessa
Gonçalves, Joana
Fontes-Ribeiro, Carlos
Silva, Ana Paula
author_facet Coelho-Santos, Vanessa
Gonçalves, Joana
Fontes-Ribeiro, Carlos
Silva, Ana Paula
author_sort Coelho-Santos, Vanessa
collection PubMed
description BACKGROUND: It is well known that methamphetamine (METH) is neurotoxic and recent studies have suggested the involvement of neuroinflammatory processes in brain dysfunction induced by misuse of this drug. Indeed, glial cells seem to be activated in response to METH, but its effects on microglial cells are not fully understood. Moreover, it has been shown that cytokines, which are normally released by activated microglia, may have a dual role in response to brain injury. This led us to study the toxic effect of METH on microglial cells by looking to cell death and alterations of tumor necrosis factor-alpha (TNF-α) and interleukine-6 (IL-6) systems, as well as the role played by these cytokines. METHODS: We used the N9 microglial cell line, and cell death and proliferation were evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling assay and incorporation of bromodeoxyuridine, respectively. The TNF-α and IL-6 content was quantified by enzyme-linked immunosorbent assay, and changes in TNF receptor 1, IL-6 receptor-alpha, Bax and Bcl-2 protein levels by western blotting. Immunocytochemistry analysis was also performed to evaluate alterations in microglial morphology and in the protein expression of phospho-signal transducer and activator of transcription 3 (pSTAT3). RESULTS: METH induced microglial cell death in a concentration-dependent manner (EC(50) = 1 mM), and also led to significant morphological changes and decreased cell proliferation. Additionally, this drug increased TNF-α extracellular and intracellular levels, as well as its receptor protein levels at 1 h, whereas IL-6 and its receptor levels were increased at 24 h post-exposure. However, the endogenous proinflammatory cytokines did not contribute to METH-induced microglial cell death. On the other hand, exogenous low concentrations of TNF-α or IL-6 had a protective effect. Interestingly, we also verified that the anti-apoptotic role of TNF-α was mediated by activation of IL-6 signaling, specifically the janus kinase (JAK)-STAT3 pathway, which in turn induced down-regulation of the Bax/Bcl-2 ratio. CONCLUSIONS: These findings show that TNF-α and IL-6 have a protective role against METH-induced microglial cell death via the IL-6 receptor, specifically through activation of the JAK-STAT3 pathway, with consequent changes in pro- and anti-apoptotic proteins.
format Online
Article
Text
id pubmed-3391183
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33911832012-07-07 Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway Coelho-Santos, Vanessa Gonçalves, Joana Fontes-Ribeiro, Carlos Silva, Ana Paula J Neuroinflammation Research BACKGROUND: It is well known that methamphetamine (METH) is neurotoxic and recent studies have suggested the involvement of neuroinflammatory processes in brain dysfunction induced by misuse of this drug. Indeed, glial cells seem to be activated in response to METH, but its effects on microglial cells are not fully understood. Moreover, it has been shown that cytokines, which are normally released by activated microglia, may have a dual role in response to brain injury. This led us to study the toxic effect of METH on microglial cells by looking to cell death and alterations of tumor necrosis factor-alpha (TNF-α) and interleukine-6 (IL-6) systems, as well as the role played by these cytokines. METHODS: We used the N9 microglial cell line, and cell death and proliferation were evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling assay and incorporation of bromodeoxyuridine, respectively. The TNF-α and IL-6 content was quantified by enzyme-linked immunosorbent assay, and changes in TNF receptor 1, IL-6 receptor-alpha, Bax and Bcl-2 protein levels by western blotting. Immunocytochemistry analysis was also performed to evaluate alterations in microglial morphology and in the protein expression of phospho-signal transducer and activator of transcription 3 (pSTAT3). RESULTS: METH induced microglial cell death in a concentration-dependent manner (EC(50) = 1 mM), and also led to significant morphological changes and decreased cell proliferation. Additionally, this drug increased TNF-α extracellular and intracellular levels, as well as its receptor protein levels at 1 h, whereas IL-6 and its receptor levels were increased at 24 h post-exposure. However, the endogenous proinflammatory cytokines did not contribute to METH-induced microglial cell death. On the other hand, exogenous low concentrations of TNF-α or IL-6 had a protective effect. Interestingly, we also verified that the anti-apoptotic role of TNF-α was mediated by activation of IL-6 signaling, specifically the janus kinase (JAK)-STAT3 pathway, which in turn induced down-regulation of the Bax/Bcl-2 ratio. CONCLUSIONS: These findings show that TNF-α and IL-6 have a protective role against METH-induced microglial cell death via the IL-6 receptor, specifically through activation of the JAK-STAT3 pathway, with consequent changes in pro- and anti-apoptotic proteins. BioMed Central 2012-07-06 /pmc/articles/PMC3391183/ /pubmed/22642790 http://dx.doi.org/10.1186/1742-2094-9-103 Text en Copyright ©2012 Coelho-Santos et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Coelho-Santos, Vanessa
Gonçalves, Joana
Fontes-Ribeiro, Carlos
Silva, Ana Paula
Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway
title Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway
title_full Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway
title_fullStr Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway
title_full_unstemmed Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway
title_short Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway
title_sort prevention of methamphetamine-induced microglial cell death by tnf-α and il-6 through activation of the jak-stat pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391183/
https://www.ncbi.nlm.nih.gov/pubmed/22642790
http://dx.doi.org/10.1186/1742-2094-9-103
work_keys_str_mv AT coelhosantosvanessa preventionofmethamphetamineinducedmicroglialcelldeathbytnfaandil6throughactivationofthejakstatpathway
AT goncalvesjoana preventionofmethamphetamineinducedmicroglialcelldeathbytnfaandil6throughactivationofthejakstatpathway
AT fontesribeirocarlos preventionofmethamphetamineinducedmicroglialcelldeathbytnfaandil6throughactivationofthejakstatpathway
AT silvaanapaula preventionofmethamphetamineinducedmicroglialcelldeathbytnfaandil6throughactivationofthejakstatpathway